Verano Holdings (VRNO) Total Current Liabilities (2021 - 2026)

Verano Holdings (VRNO) reported Total Current Liabilities of $118.9 million for Q1 2026, down 29.07% year-over-year from $167.6 million in Q1 2025, and down 15.22% quarter-over-quarter from $140.3 million in Q4 2025.

Verano Holdings (VRNO) Total Current Liabilities (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Total Current Liabilities data on file, last reported at $118.9 million in Q1 2026.

  • Total Current Liabilities for Q1 2026 came in at $118.9 million, down 29.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $118.9 million (down 29.07% YoY), and the FY2025 annual result was $140.3 million, down 30.94% from the prior year.
  • Total Current Liabilities retreated to $118.9 million in Q1 2026 per VRNO's latest filing, from $140.3 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $586.8 million in Q2 2022 and troughed at $118.9 million in Q1 2026.
  • A 5-year average of $310.4 million and a median of $356.4 million in 2023 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2024 and 2025: Total Current Liabilities grew 23.58% in 2024, then plunged 67.06% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $386.6 million in 2022, then increased by 6.61% to $412.2 million in 2023, then tumbled by 50.72% to $203.1 million in 2024, then sank by 30.94% to $140.3 million in 2025, then retreated by 15.22% to $118.9 million in 2026.
  • Business Quant data shows VRNO's Total Current Liabilities at $118.9 million in Q1 2026, $140.3 million in Q4 2025, and $143.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.53 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 2.05 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 831.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 1.66 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 599.50 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 618.78 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 333.17 Mn
10 Verano Holdings - - 98.98 Mn 118.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 118.91 Mn
Dec 31, 2025 140.26 Mn
Sep 30, 2025 143.41 Mn
Jun 30, 2025 147.83 Mn
Mar 31, 2025 167.64 Mn
Dec 31, 2024 203.11 Mn
Sep 30, 2024 435.38 Mn
Jun 30, 2024 360.59 Mn
Mar 31, 2024 414.98 Mn
Dec 31, 2023 412.19 Mn
Sep 30, 2023 352.30 Mn
Jun 30, 2023 348.32 Mn
Mar 31, 2023 363.39 Mn
Dec 31, 2022 386.65 Mn
Sep 30, 2022 384.20 Mn
Jun 30, 2022 586.78 Mn
Dec 31, 2021 470.52 Mn